頭と首の状細胞がんに対する新しい治療戦略:EGFRとチェックポイントブロックを超えて
PubMedで要約を見る
まとめ
この要約は機械生成です。現在の免疫療法に対する耐性のために,頭頸部状細胞癌 (HNSCC) に対して新しい治療法が研究されている. このレビューでは,チェックポイント阻害剤以外の新興治療法を検討し,患者の治療結果を改善します.
科学分野
- 腫瘍学
- 免疫療法
- 薬物の発見
背景
- ヘッド・アンド・ネック・スクワモス・セル癌 (HNSCC) は,チェックポイント阻害剤を含む現在の免疫療法に対する限られた反応と獲得抵抗を示しています.
- EGFR阻害やPD-1/PD- L1阻害のような確立された治療法は,重要な患者のサブセットでは不十分です.
研究 の 目的
- 現在の治療基準を超えたHNSCCの新たな治療戦略を検討する.
- HNSCCにおける治療抵抗性を克服する可能性を秘めた新興の標的と薬剤のクラスを調査する.
主な方法
- 新しいHNSCC治療法に関する臨床前および臨床データの文献レビュー.
- 次世代の免疫療法,標的治療薬,表遺伝子変異剤,腫瘍微環境変調剤,細胞ベースの治療法,腫瘍ウイルスに焦点を当てます.
主要な成果
- HNSCCの新たな治療法をいくつか発見しました
- これらの新興治療法の根拠と利用可能な臨床的証拠について議論しました.
結論
- これらの新しい戦略を臨床実用化することは困難ですが,HNSCC患者の成果を改善するための重要な機会を提供します.
- HNSCCに対するこれらの高度な治療方法の検証と実施には,さらなる研究と臨床試験が不可欠です.
関連する概念動画
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

